Sinovac Biotech, Ltd. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (14)

Latest Posts

About This Stock More About This Stock
Week In Review: Beijing's Berry Genomics Valued At $619 Million In Reverse Merger
Article By: ChinaBio® Today
Saturday, December 24, 2016 4:36 PM EDT
Berry Genomics, a Beijing genetic testing company, will IPO via a reverse merger with Chengdu Tianxing Instrument & Meter (SHZ: 0710) at a valuation of $619 million on China's Shenzhen market.
In this article: SVA, BGNE
Read
Week In Review: New Deals Fund China Life Science Innovation
Article By: ChinaBio® Today
Saturday, September 3, 2016 1:30 PM EDT
Beijing Allcure Medical Technology, a radiology oncology startup developing big data/cloud computing applications, raised $27 million in an A+ funding round.
In this article: CCM, SVA
Read
Week In Review: HighLight Capital Raising $229 Million For China Healthcare
Article By: ChinaBio® Today
Saturday, May 28, 2016 12:30 PM EDT
HighLight Capital of Shanghai, a healthcare early-stage private equity investor, is close to completing fundraising for its $229 million second fund, according to media reports.
In this article: SVA
Read
Week In Review: Deals Dominate China Biopharma News
Article By: ChinaBio® Today
Saturday, April 2, 2016 1:53 PM EDT
AliHealth, a subsidiary of China e-commerce giant Alibaba, will invest $35 million to acquire a 25% stake in China Resources Wandong Medical Equipment's medical imaging unit.
In this article: AIQ, GSK, TMO, AFFY, SVA, BABA
Read
Week In Review: BeiGene Completes $158 Million IPO In The US
Article By: ChinaBio® Today
Saturday, February 6, 2016 11:43 AM EDT
The company priced the offering at the top of the expected range -- $24 per share -- and increased its size from 5.5 million ADSs to 6.6 million. In its first day of trading, the company's stock rose $4.62 to $28.62, a 19% increase.
In this article: SVA, CBMG, BGNE
Read

PARTNER HEADLINES

Latest Tweets for $SVA

No tweets yet!